 |
 |
【參考文獻】
1 Chlebowski RT，Kuller LH，Prentice RL，et al.Breast cancer after use of estrogen plus progestin in postmenopausal women.N Engl J Med，2009，360：573587.
2 Chevallier B，Heintzmann F，Mosseri V，et al.Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis.Cancer， 1988，62：25172524.
3 Gnant M，Mlineritsch B，Schippinger W，et al.Endocrine therapy plus zoledronic acid in premenopausal breast cancer.N Engl J Med，2009，360：679691.
4 Shippinger W，Regitnig P，Dandachi N，et al.Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer.Virchows Arch，2006，449：2430.
5 Carreno G， Del Casar JM， Corte MD， et al. Local recurrence after mastectomy for breast cancer：analysis of clinicopathological， biological and prognostic charactersitics. Breast Cancer Res Treat，2006，6：4348.
6 Allegra JC，Woodcock T，Woolf S，et al.A randomized trial comparing mitoxantrone with doxorubicin in patients with stage Ⅳ breast cancer. Invest New Drugs，1985，3：153161.
7 Kumar R， Johnson BH， Thampson EB. Overview of the structural basis for transcription regulation by nuclear hormone receptors.Essays Biochem，2004，40：2739醫(yī).學全.在.線網(wǎng)站m.payment-defi.com.
8 Ogawa Y，Hai E，Matsumoto K，et al. Androgen receptor expression in breast cancer：relationship with clinicopathological factors and biomarkers. Int J Clin Oncol，2008，13：431435.
9 Moinfar F，Okcu M，Tsybrovskyy O， et al. Androgen receptors frequently are expressed in breast carcinomas potential relevance to new therapeutic strategies. Cancer， 2003，98： 703711.
10 Agrawal A K，Jilen M， Grzebieniak Z，et al.Androgen receptors as a prognostic and predictive factor in breast cancer.Folia Histochem Cytobiol， 2008，46：269276.
